{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:10:13Z","timestamp":1759050613279,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019637","name":"Horizon Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jneuroim.2023.578099","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T02:30:56Z","timestamp":1683253856000},"page":"578099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report"],"prefix":"10.1016","volume":"379","author":[{"given":"Giovanna S.","family":"Manzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan R.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Zurawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youmna","family":"Jalkh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrah J.","family":"Mateen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jneuroim.2023.578099_bb0005","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0000000000003820","article-title":"Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases","volume":"88","author":"Absinta","year":"2017","journal-title":"Neurology."},{"issue":"7","key":"10.1016\/j.jneuroim.2023.578099_bb0010","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00415-006-0137-8","article-title":"Inflammatory\/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?","volume":"253","author":"Akman-Demir","year":"2006","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578099_bb0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1468-1331.2010.02948.x","article-title":"Rapidly progressive Creutzfeldt-Jakob disease in patients with familial Mediterranean fever","volume":"17","author":"Appel","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578099_bb0020","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/rheumatology\/kez410","article-title":"Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients","volume":"59","author":"Balc\u0131-Peynircio\u011flu","year":"2020","journal-title":"Rheumatology."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578099_bb0025","first-page":"342","article-title":"Co-existence of familial Mediterranean fever and multiple sclerosis in two patients","volume":"39","author":"Ceylan","year":"2014","journal-title":"Acta Reumatol. Port."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578099_bb0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.46497\/ArchRheumatol.2021.8229","article-title":"Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis","volume":"36","author":"Demir","year":"2021","journal-title":"Arch. Rheumatol."},{"key":"10.1016\/j.jneuroim.2023.578099_bb0035","first-page":"50","article-title":"Association between familial Mediterranean fever and multiple sclerosis: a case series from the JIR cohort and systematic literature review","author":"Elhani","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578099_bb0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jon.12444","article-title":"Leptomeningeal enhancement at 7T in multiple sclerosis: frequency, morphology, and relationship to cortical volume","volume":"27","author":"Harrison","year":"2017","journal-title":"J. Neuroimaging"},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578099_bb0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028969","article-title":"Magnetic resonance imaging in multiple sclerosis","volume":"8","author":"Hemond","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578099_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MD.0b013e3181d5dca7","article-title":"Familial Mediterranean fever and central nervous system involvement: a case series","volume":"89","author":"Kalyoncu","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578099_bb0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00296-021-04821-7","article-title":"Familial coexistence of demyelinating diseases and familial Mediterranean fever","volume":"42","author":"Korkmaz","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2023.578099_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102332","article-title":"The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis","volume":"45","author":"Ozdogan","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2023.578099_bb0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fimmu.2017.00253","article-title":"Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management","volume":"8","author":"\u00d6zen","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2023.578099_bb0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5606\/ArchRheumatol.2019.7249","article-title":"Familial Mediterranean fever and multiple sclerosis successfully treated with interferon Beta-1a: a case report","volume":"34","author":"\u00d6zturk","year":"2019","journal-title":"Arch. Rheumatol."},{"key":"10.1016\/j.jneuroim.2023.578099_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.591395","article-title":"Case report: efficacy of rituximab in a patient with familial mediterranean fever and multiple sclerosis","volume":"11","author":"Pozzato","year":"2021","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2023.578099_bb0080","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.semarthrit.2019.12.003","article-title":"Neurological manifestations of autoinflammatory diseases in Chinese adult patients","volume":"50","author":"Qin","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578099_bb0085","first-page":"309","article-title":"A case with multiple sclerosis and familial Mediterranean fever","volume":"22","author":"Sayin","year":"2011","journal-title":"Genet. Couns Geneva Switz."},{"issue":"3","key":"10.1016\/j.jneuroim.2023.578099_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.gene.6363967","article-title":"Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients","volume":"4","author":"Shinar","year":"2003","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578099_bb0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/00207454.2014.913170","article-title":"The relationship between familial Mediterranean fever gene (MEFV) mutations and clinical and radiologic parameters in multiple sclerosis patients","volume":"125","author":"Terzi","year":"2015","journal-title":"Int. J. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578099_bb0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578099_bb0105","first-page":"117","article-title":"Familial mediterranean fever and multiple sclerosis\u2014a case report","volume":"34","author":"Ugurlu","year":"2009","journal-title":"Acta Reumatol. Port."},{"issue":"5","key":"10.1016\/j.jneuroim.2023.578099_bb0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4103\/0028-3886.57790","article-title":"The co-incidence of multiple sclerosis in a patient with familial Mediterranean fever","volume":"57","author":"Unal","year":"2009","journal-title":"Neurol. India"},{"issue":"1","key":"10.1016\/j.jneuroim.2023.578099_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2010.04.008","article-title":"Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients: is it a susceptibility gene?","volume":"294","author":"Unal","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"9","key":"10.1016\/j.jneuroim.2023.578099_bb0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1468-1331.2011.03356.x","article-title":"Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world\u2019s largest FMF cohorts","volume":"18","author":"Yahalom","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2023.578099_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1352458519885106","article-title":"7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions","volume":"26","author":"Zurawski","year":"2020","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:42:24Z","timestamp":1759048944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":25,"alternative-id":["S0165572823000851"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578099","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578099"}}